Recent Finacing
Recent Raise
Caldera Therapeutics is a clinical-stage biotech developing CLD-423, a first-in-class bispecific antibody for inflammatory bowel disease and other immune-mediated disorders.
Focus Areas
Recent Investors
Total Raised
Funding round